Lana Medical Co.

9587.SRSAUHealthcare● Active

$2.79

$-0.01(-0.36%)

Market Cap$150660000

P/E Ratio—

52W High$3.934

52W Low$2.07

Avg Volume78K

Open$2.70

Beta-0.12

Free Cash Flow Financials Revenue

Lana Medical Co. (9587.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

9587.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

9587.SR · FCF · TTM · margin & CAGR

Free cash flow was −$13.7M for FY2025 (fiscal year ending 2025-12-31), down 267.7% year-over-year The FCF margin was -14.8%.

FY2025 Free Cash Flow−$13.7M▼ -267.7% YoY

Trailing 12M (TTM)−$17.9Mtrailing 4 quarters sum

FCF Margin-14.8%−$13.7M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

9587.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$9.0M(5M)−$13.7M▼ 267.7%-14.8%

FY2024$393,205(4M)−$3.7M▼ 361.0%-4.4%

FY2023$1.4M(0M)$1.4M▲ +301.7%2.9%

FY2022$5.5M(5M)$355,564▲ +102.9%0.9%

FY2021−$4.9M(7M)−$12.2M▼ 364.9%-38.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

9587.SR · P/FCF · FCF yield · FCF per share

Lana Medical Co. (9587.SR) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

9587.SR · cash flow statement · operating / investing / financing

For FY2025, Lana Medical Co. generated −$9.0M in operating cash flow and spent 5M in capital expenditures, yielding −$13.7M in free cash flow.

Operating Activities

−$9.0M

Cash from core business operations

2025-12-31

Investing Activities

−$3.5M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$10.7M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$9.0M) − |CapEx| (5M) = FCF (−$13.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

9587.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Lana Medical Co.YOU

9587.SR

−$13.7M-267.7%-14.8%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Lana Medical Co. (9587.SR) reported free cash flow of −$13.7M for FY2025 (fiscal year ending 2025-12-31), down 267.7% year-over-year. The FCF margin was -14.8%.

Based on available data, Lana Medical Co. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $2.4M in FY2019.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

9587.SR free cash flow · 8 questions

Lana Medical Co. free cash flow was −$13.7M for FY2025, down 267.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$17.9M.

9587.SR free cash flow9587.SR FCF9587.SR FCF 20259587.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Lana Medical Co. · Lana Medical Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026